Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
azacitidine (vidaza) (1 trial)
decitabine (dacogen) (1 trial)
Myelodysplastic Syndromes (Phase 2)
Trials (1 total)
Trial APIs (2 total)